BlueRock Therapeutics

(15:8)

Meet BlueRock Therapeutics - A Leaps Portfolio Company

(1:59)

Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rakhit

(31:15)

BlueRock Therapeutics

(19:55)

BlueRock Therapeutics

(13:8)

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

(29:40)

Lab Tour

(1:20)

BlueRock Therapeutics

(14:51)

Parkinson's Disease:- Research takeaways from 2024 and research to be looking for in 2025

(1:30:55)

Rebranding\

(1:53:18)

Stem Cells and Parkinson’s Disease Research Advances + Patient Experiences

(1:29:52)

Finding a Drug to Treat Lymphedema: An Update

(1:24)

Updates in Therapeutics for Parkinson’s Disease

(56:50)

Stem Cells, Cell Replacement, and Parkinson's: A Conversation with Dr. Roger Barker

(53:5)

Age Reversal In Mexico: Follistatin \u0026 Klotho Gene Therapy, NK Killer Cell Infusion \u0026 More

(56:49)

National Chapter Vision Webinar | Clinical Trials - December 7, 2024

(1:33:9)

Foundation Fighting Blindness | Insights Forum 5.23.24

(1:1:54)

Gene \u0026 Cell-based Therapies in Parkinson's

(1:1:51)

Bluerock Therapeutics

(10:53)

BlueRock Therapeutics - Summer Internship Spotlight

(5:7)

BlueRock Therapeutics

(16:21)

The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg

(28:36)

BlueRock Therapeutics

(14:17)

BlueRock Therapeutics

(12:1econd)

BlueRock Therapeutics

(16:39)

Bluerock Therapeutics

(13:42)

Bluerock Therapeutics

(14:9)

IP: Using it to your advantage

(38:12)

Mauricio speaks to why he works at BlueRock

(26)